Oral alkalinizing supplementation suppressed intrarenal reactive oxidative stress in mild-stage chronic kidney disease: a randomized cohort study.
Abe M, Yamaguchi T, Koshiba S, Takayama S, Nakai T, Nishioka K, Yamasaki S, Kawaguchi K, Umeyama M, Masaura A, Ishizawa K, Arita R, Kanno T, Akaishi T, Miyazaki M, Abe T, Tanaka T, Ishii T; CKOALA study group.
Abe M, et al.
Clin Exp Nephrol. 2024 Jun 13. doi: 10.1007/s10157-024-02517-3. Online ahead of print.
Clin Exp Nephrol. 2024.
PMID: 38872014